Influence of Age and Neurotoxic HAART Use on Frequency of HIV Sensory Neuropathy

Table 1

Demographic and clinical characteristics of 323 participants in the HIV-SN study.

Variables	All; 𝑁=323	HAART treated 𝑁=142	HAART naïve 𝑁=181	𝑃 value
Male	105 (32.5%)	45 (31.7%)	60 (33.1%)	0.81
Female	218 (67.5%)	97 (68.3%)	121 (66.9%)
Mean age ± SD (years)	36.7±9.8	38.3±10.8	35.5±8.7	0.009
Age category >40 years	9 (30.0%)	51 (52.6%)	48 (49.5%)	0.09
Mean height ± SD, metres	1.61±0.08	1.59±0.07	1.62±0.09	0.000
Height category >1.7 metres	44 (13.6%)	4 (2.8%)	40 (22.1%)	0.000
Mean CD4 count ± SD, cells/mm^3	214.5±153.4	246.1±152.2	189.7±150.1	0.001
CD4 count >200, cells/mm^3	147 (45.5%)	81 (57.0%)	66 (36.5%)	0.000
CD4 count ≤200, cells/mm^3	176 (54.5%)	61 (43.0%)	115 (63.5%)